Baidu (NASDAQ:BIDU) Lowered to Sell at Zacks Investment Research

Cornelia Mascio
Gennaio 20, 2018

The company has market cap of 2.02 billion GBP. Pluristem Therapeutics Inc. (NASDAQ:PSTI) has declined 7.80% since January 17, 2017 and is downtrending. It has underperformed by 10.81% the S&P500. Wells Fargo maintained Baidu, Inc. Lowe Brockenbrough has 8,057 shares for 1.19% of their portfolio.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Northwestern Mutual Wealth Management Company who had been investing in Baidu Inc for a number of months, seems to be less bullish one the $91.20B market cap company. The stock increased 1.47% or $0.51 during the last trading session, reaching $35.16. About 3.04 million shares traded or 19.92% up from the average. It has underperformed by 4.68% the S&P500. Bernstein initiated Baidu, Inc. (NYSE:OAS) to report earnings on February, 28. The stock decreased 3.14% or $0.05 during the last trading session, reaching $1.54. BIDU's profit will be $576.39 million for 38.53 P/E if the $1.66 EPS becomes a reality. After $0.35 actual earnings per share reported by KBR, Inc. for the previous quarter, Wall Street now forecasts -14.29% negative EPS growth. (NASDAQ:AMZN). Autus Asset Management Ltd Company owns 2,586 shares or 0.48% of their U.S. portfolio. It also increased its holding in British Amern Tob Plc (NYSEMKT:BTI) by 5,491 shares in the quarter, for a total of 13,275 shares, and has risen its stake in Hca Healthcare Inc (NYSE:HCA). Two research analysts have rated the stock with a sell rating, nine have given a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. Therefore 38% are positive. Macquarie lowered shares of Baidu from an "outperform" rating to a "neutral" rating and decreased their price target for the stock from $199.00 to $179.00 in a research report on Friday, October 28th.

TRADEMARK VIOLATION WARNING: "DAVENPORT & Co LLC Has $585,000 Holdings in Baidu Inc (BIDU)" was first published by BBNS and is the sole property of of BBNS. Vetr upgraded shares of Baidu from a "buy" rating to a "strong-buy" rating and set a $194.90 price target on the stock in a research report on Wednesday, October 26th.

Several research analysts have issued reports on BIDU shares. More interesting news about Baidu, Inc. The firm has "Hold" rating by Brean Capital given on Tuesday, July 28. The firm earned "Buy" rating on Monday, June 19 by Jefferies. H.C. Wainwright maintained Pluristem Therapeutics Inc. The firm has "Buy" rating by Citigroup given on Friday, July 29. As per Monday, October 30, the company rating was maintained by JP Morgan. (NASDAQ:BIDU) on Friday, July 29 to "Hold" rating. (NASDAQ:BIDU) has "Buy" rating given on Monday, July 31 by Nomura. The rating was upgraded by CapitalOne to "Overweight" on Wednesday, October 19. The firm has "Hold" rating by Deutsche Bank given on Wednesday, September 28. Pluristem Therapeutics had 12 analyst reports since August 14, 2015 according to SRatingsIntel. This rating was disclosed in a research report on 27 October. Financial Architects Inc now owns 775 shares of the company's stock valued at $141,000 after buying an additional 300 shares during the period. (NYSE:KW) earned "Buy" rating by BTIG Research on Monday, November 6. Maxim Group maintained Pluristem Therapeutics Inc. The rating was downgraded by KeyBanc Capital Markets to "Sector Weight" on Tuesday, July 28.

Analysts await Oasis Petroleum Inc. San Francisco Sentry Investment Group CA raised its position in shares of Baidu by 5.4% in the second quarter.

Investors sentiment decreased to 1.62 in Q3 2017. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.71 and a quick ratio of 1.71. It is positive, as 5 investors sold Pluristem Therapeutics Inc. shares while 1 reduced holdings. Finally, Lazard Asset Management LLC boosted its stake in shares of Baidu by 2.4% during the 2nd quarter. The Massachusetts-based Martingale Asset LP has invested 0.55% in, Inc. (NASDAQ:PSTI). Jpmorgan Chase & Communications accumulated 8,300 shares. About 1.47 million shares traded. Partner Mgmt Ltd Partnership invested 2.01% of its portfolio in, Inc. Security Natl Trust holds 0.98% or 3,082 shares in its portfolio. Comerica Natl Bank holds 170,659 shares or 0.02% of its portfolio. (NASDAQ:PSTI). Van Eck Corp reported 31,038 shares. 2,077 shares were sold by Blackburn Jeffrey M, worth $2.05 million on Tuesday, August 15.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE